Interleukin‐12p40 overexpression promotes interleukin‐12p70 and interleukin‐23 formation but does not affect bacille Calmette–Guérin and Mycobacterium tuberculosis clearance
Open Access
- 9 July 2007
- journal article
- Published by Wiley in Immunology
- Vol. 122 (3), 350-361
- https://doi.org/10.1111/j.1365-2567.2007.02646.x
Abstract
Interleukin (IL)-12p40, a subunit of IL-12p70 and IL-23, has previously been shown to inhibit IL-12p70 activity and interferon-γ (IFN-γ) production. However, recent evidence has suggested that the role of IL-12p40 is more complex. To study the contribution of IL-12p40 to immune responses against mycobacterial infections, we have used transgenic (tg) mice overexpressing IL-12p40 under the control of a major histocompatibility complex-II promoter. The IL-12p40 transgene was expressed during steady state at concentrations of 129 ± 25 ng/ml of serum and 75 ± 13 ng per spleen, while endogenous IL-12p40 was hardly detectable in control littermates. Bacille Calmette–Guérin (BCG) infection strongly induced the expression of IL-12p40 transgene in infected organs, and IL-12p40 monomeric and dimeric forms were identified in spleen of IL-12p40 tg mice. Excessive production of IL-12p40 resulted in a 14-fold increase in IL-12p70 serum levels in tg mice versus non-transgenic mice. IL-23 was also strongly elevated in the serum and spleens of IL-12p40 tg mice through BCG infection. While IFN-γ and tumour necrosis factor protein levels were similar in IL-12p40 tg and non-transgenic mice, Th2 type immune responses were reduced in IL-12p40 tg mice. The number of BCG granulomas and macrophage expressing inducible nitric oxide synthase were similar in IL-12p40 tg and non-transgenic mice. IL-12p40 tg mice were as resistant as non-transgenic mice to BCG and Mycobacterium tuberculosis infections as they could efficiently control bacillary growth. These data show that high amounts of IL-12p40 promotes IL-12p70 and IL-23 formation, but that does not affect T helper 1 type immune responses and granuloma function, thus leading to normal mycobacterial clearance in infected organs.Keywords
This publication has 48 references indexed in Scilit:
- Neutralization or Absence of the Interleukin-23 Pathway Does Not Compromise Immunity to Mycobacterial InfectionInfection and Immunity, 2006
- Interleukin 12p40 is required for dendritic cell migration and T cell priming afterMycobacterium tuberculosisinfectionThe Journal of Experimental Medicine, 2006
- Interleukin-12p40 mediates transient protection against Mycobacterium avium infection in the absence of interleukin-12Immunobiology, 2005
- Inhibition of inducible nitric oxide synthase protects against liver injury induced by mycobacterial infection and endotoxinsJournal of Hepatology, 2004
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- Mouse interleukin‐12 (IL‐12) p40 homodimer: a potent IL‐12 antagonistEuropean Journal of Immunology, 1995
- The interleukin‐12 subunit p40 specifically inhibits effects of the interleukin‐12 heterodimerEuropean Journal of Immunology, 1993
- Interleukin-12 and its role in the generation of TH1 cellsImmunology Today, 1993
- Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced MacrophagesScience, 1993
- Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.The Journal of Experimental Medicine, 1992